Monday, October 26, 2026
  • About Web3Wire
  • Web3Wire NFTs
  • .w3w TLD
  • $W3W Token
  • Web3Wire DAO
  • Media Network
  • RSS Feed
  • Contact Us
Web3Wire
No Result
View All Result
  • Home
  • Web3
    • Latest
    • AI
    • Business
    • Blockchain
    • Cryptocurrencies
    • Decentralized Finance
    • Metaverse
    • Non-Fungible Token
    • Press Release
  • Technology
    • Consumer Tech
    • Digital Fashion
    • Editor’s Choice
    • Guides
    • Stories
  • Coins
    • Top 10 Coins
    • Top 50 Coins
    • Top 100 Coins
    • All Coins
  • Exchanges
    • Top 10 Crypto Exchanges
    • Top 50 Crypto Exchanges
    • Top 100 Crypto Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks
  • Events
  • News
    • Latest Crypto News
    • Latest DeFi News
    • Latest Web3 News
  • Home
  • Web3
    • Latest
    • AI
    • Business
    • Blockchain
    • Cryptocurrencies
    • Decentralized Finance
    • Metaverse
    • Non-Fungible Token
    • Press Release
  • Technology
    • Consumer Tech
    • Digital Fashion
    • Editor’s Choice
    • Guides
    • Stories
  • Coins
    • Top 10 Coins
    • Top 50 Coins
    • Top 100 Coins
    • All Coins
  • Exchanges
    • Top 10 Crypto Exchanges
    • Top 50 Crypto Exchanges
    • Top 100 Crypto Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks
  • Events
  • News
    • Latest Crypto News
    • Latest DeFi News
    • Latest Web3 News
No Result
View All Result
Web3Wire
No Result
View All Result
Home Press Release GlobeNewswire

Neuro Cinnamon Capsules Introduces Neuro Cinnamon Multi-Ingredient Dietary Supplement Featuring Five Ingredients

October 26, 2026
in GlobeNewswire, Web3
Reading Time: 23 mins read
5
SHARES
246
VIEWS
Share on TwitterShare on LinkedInShare on Facebook

A suppleme t fo mulatio featu i g b a ched-chai ami o acids, Bacopa mo ie i, Rhodiola osea, L-thea i e, a d Pa ax gi se g eflects a app oach to combi i g ami o acids a d bota ical i g edie ts i a si gle p oduct.

Ogde , UT, Oct. 26, 2026 (GLOBE NEWSWIRE) — Neu o Ci amo has i t oduced Neu o Ci amo Capsules a multi-i g edie t dieta y suppleme t featu i g five i g edie ts commo ly associated with spo ts ut itio , t aditio al bota ical use, a d co tempo a y suppleme t fo mulatio s. The fo mula i cludes b a ched-chai ami o acids (BCAAs) i a 2:1:1 atio, Bacopa mo ie i ext act, Rhodiola osea oot powde , L-thea i e, a d Pa ax gi se g ext act.

OFFICIAL WEBSITE Neu o Ci amo

The fo mulatio b i gs togethe ami o acids a d pla t-de ived i g edie ts i o e suppleme t. Each i g edie t has a disti ct backg ou d, compositio , a d histo y of use i dieta y suppleme t p oducts. U de sta di g these diffe e ces p ovides useful co text fo co sume s who wa t to lea mo e about multi-i g edie t fo mulatio s a d the co side atio s i volved i selecti g dieta y suppleme ts.

The i t oductio of the Neu o Ci amo also p ovides a oppo tu ity to discuss i g edie t t a spa e cy, espo sible suppleme t use, a d the impo ta ce of evaluati g available scie tific evide ce befo e d awi g co clusio s about pote tial health effects.

A Fo mulatio Combi i g Ami o Acids a d Bota ical I g edie ts

Neu o Ci amo Multi-i g edie t dieta y suppleme ts combi e seve al compo e ts withi o e p oduct. Depe di g o thei compositio a d i te ded use, these p oducts may i clude ami o acids, bota ical ext acts, vitami s, mi e als, o othe ut itio al i g edie ts.

The Neu o Ci amo fo mulatio co tai s five amed i g edie ts, each ep ese ti g a diffe e t catego y of ut itio al o bota ical esea ch.

B a ched-chai ami o acids a e esse tial ami o acids i volved i p otei metabolism. Bacopa mo ie i is a pla t t aditio ally used i Ayu vedic p actices a d studied fo seve al pote tial biological effects. Rhodiola osea is a bota ical associated with t aditio al use i egio s of Eu ope a d Asia. L-thea i e is a ami o acid atu ally fou d i tea, while Pa ax gi se g is a medici al pla t with a lo g histo y of use i t aditio al East Asia p actices.

Neu o Ci amo Although these i g edie ts have appea ed i va ious suppleme t fo mulatio s, thei p ese ce i a combi ed p oduct does ot establish that the fi ished suppleme t p oduces a pa ticula health outcome. Resea ch o i dividual i g edie ts may use diffe e t p epa atio s, co ce t atio s, populatio s, a d study desig s f om those eleva t to a fi ished comme cial p oduct.

Fo this easo , evaluati g a multi-i g edie t suppleme t equi es atte tio to both the ide tity of its i g edie ts a d the evide ce available fo the actual fo mulatio .

B a ched-Chai Ami o Acids i a 2:1:1 Ratio

B a ched-chai ami o acids, commo ly abb eviated as BCAAs, co sist of leuci e, isoleuci e, a d vali e. These th ee esse tial ami o acids must be obtai ed th ough food o othe dieta y sou ces because the huma body ca ot sy thesize them i sufficie t amou ts.

The 2:1:1 atio ge e ally efe s to the elative qua tities of leuci e, isoleuci e, a d vali e, espectively. Leuci e is the efo e p ese t at twice the amou t of eithe of the othe two ami o acids i this specified atio.

BCAAs pa ticipate i p otei metabolism a d o mal physiological p ocesses. They a e also f eque tly i cluded i spo ts ut itio p oducts because of thei elatio ship to muscle p otei metabolism a d exe cise- elated esea ch.

Howeve , ami o acid suppleme tatio should be co side ed i the co text of ove all dieta y i take, exe cise habits, a d i dividual ut itio al equi eme ts. Adequate p otei ca be obtai ed f om a va iety of foods, i cludi g dai y p oducts, eggs, legumes, fish, meat, soy p oducts, a d othe p otei -co tai i g foods.

The p ese ce of BCAAs i Neu o Ci amo ide tifies o e compo e t of the p oduct’s fo mulatio . The stated atio alo e does ot establish the total qua tity supplied pe se vi g o demo st ate a pa ticula effect o physical pe fo ma ce, ecove y, o ge e al health.

Co sume s i te ested i this i g edie t ca eview the p oduct’s complete label, i cludi g se vi g size a d the qua tities of i dividual ami o acids, whe that i fo matio is available.

Bacopa Mo ie i Ext act a d Bota ical Resea ch

Bacopa mo ie i is a c eepi g he b associated with t aditio al Ayu vedic p actices. It has bee the subject of scie tific esea ch exami i g its chemical co stitue ts a d possible effects o va ious aspects of huma physiology.

Ce tai p epa atio s of Bacopa mo ie i co tai compou ds k ow as bacosides. These compou ds a e f eque tly discussed i esea ch i vestigati g the pla t’s biological p ope ties.

Studies i volvi g Bacopa mo ie i have explo ed a eas i cludi g cog itive pe fo ma ce a d memo y. Neve theless, esea ch fi di gs va y acco di g to the p epa atio used, study du atio , pa ticipa t cha acte istics, a d outcome measu eme ts. Evide ce co ce i g o e sta da dized ext act ca ot automatically be applied to eve y p oduct co tai i g the pla t.

The te m “ext act” also does ot specify the co ce t atio o sta da dizatio of the i g edie t. Ext actio methods a d the p opo tio of ide tified co stitue ts ca diffe amo g ma ufactu e s.

Fo co sume s exami i g a suppleme t co tai i g Bacopa mo ie i, eleva t i fo matio may i clude the bota ical ame, ext act qua tity, sta da dizatio details whe e applicable, a d othe label i fo matio eeded to u de sta d the fo mulatio .

Its i clusio i Neu o Ci amo Capsules ide tifies the i g edie t as pa t of the p oduct’s bota ical compo e t. It should ot be i te p eted as p oof that the fi ished suppleme t imp oves memo y, t eats a eu ological co ditio , o p eve ts cog itive decli e.

Rhodiola Rosea Root Powde

Rhodiola osea is a pe e ial pla t that g ows i cold egio s of Eu ope a d Asia. Its oots have a histo y of use i t aditio al p actices, a d mode esea ch has exami ed the pla t’s chemical co stitue ts a d pote tial physiological effects.

The bota ical has bee studied i co ectio with fatigue, st ess- elated outcomes, a d physical o me tal pe fo ma ce. Howeve , the available evide ce is ot u ifo m, a d co clusio s depe d o the quality a d desig of i dividual studies.

O e impo ta t co side atio is the disti ctio betwee oot powde a d a sta da dized ext act. Root powde co sists of p ocessed pla t mate ial, whe eas a ext act is p oduced th ough a p ocess i te ded to co ce t ate selected co stitue ts. These fo ms may diffe i compositio a d co ce t atio .

Resea ch i volvi g a pa ticula Rhodiola osea ext act the efo e may ot di ectly establish the effects of a p oduct co tai i g oot powde .

The Neu o Ci amo fo mulatio lists Rhodiola osea oot powde as o e of its i g edie ts. Co sume s seeki g fu the i fo matio may wish to exami e the amou t pe se vi g, bota ical ide tificatio , ma ufactu i g specificatio s, a d a y available i fo matio co ce i g i g edie t quality.

The p ese ce of this bota ical does ot, o its ow , establish that the fi ished p oduct educes st ess, i c eases e e gy, o t eats fatigue.

L-Thea i e a d Its Occu e ce i Tea

L-thea i e is a ami o acid atu ally fou d i tea leaves. It has att acted scie tific i te est because of its disti ctive chemical p ope ties a d esea ch explo i g its elatio ship with elaxatio , atte tio , a d othe measu es of cog itive pe fo ma ce.

L-thea i e is commo ly i cluded i dieta y suppleme ts as a i dividual i g edie t o i combi atio with othe ut itio al compo e ts.

Studies have exami ed diffe e t doses a d combi atio s, i cludi g fo mulatio s that co tai caffei e. Fi di gs f om those studies should be i te p eted i light of the specific i g edie ts a d co ditio s exami ed. They should ot automatically be exte ded to p oducts that co tai L-thea i e alo gside u elated compou ds.

The amou t of L-thea i e i a fi ished suppleme t is eleva t whe compa i g its fo mulatio with the p epa atio s used i published esea ch. Without co fi med dosage i fo matio a d p oduct-specific evide ce, it is ot possible to dete mi e whethe a pa ticula suppleme t ep oduces the co ditio s of a y give study.

I Neu o Ci amo Capsules, L-thea i e fo ms pa t of the ove all i g edie t combi atio . Its i clusio p ovides i fo matio about the p oduct’s compositio , but it does ot i depe de tly substa tiate claims about elaxatio , co ce t atio , sleep, o st ess ma ageme t.

Co sume s should co side the complete i g edie t label a d co sult a qualified healthca e p ofessio al whe assessi g whethe a L-thea i e-co tai i g suppleme t is app op iate fo thei i dividual ci cumsta ces.

Pa ax Gi se g Ext act a d T aditio al Use

Pa ax gi se g is a pla t used i t aditio al East Asia medici e. Its oots co tai seve al biologically active compou ds, i cludi g gi se osides, which have bee i vestigated i labo ato y a d huma studies.

Resea ch o Pa ax gi se g has exami ed a a ge of outcomes, i cludi g aspects of physical pe fo ma ce, fatigue, a d metabolic fu ctio . The st e gth of the evide ce diffe s by outcome, a d esea ch esults a e i flue ced by the ext act, dosage, study populatio , a d du atio of use.

Pa ax gi se g should also be disti guished f om othe pla ts sometimes desc ibed as gi se g. Diffe e t species ca have diffe e t chemical p ofiles, maki g accu ate bota ical ide tificatio impo ta t whe i te p eti g p oduct labels a d scie tific lite atu e.

The te m “ext act” i dicates that the i g edie t has u de go e a ext actio p ocess, but it does ot eveal the co ce t atio of gi se osides o the amou t p ese t i a se vi g. Additio al p oduct i fo matio would be eeded to assess those cha acte istics.

Neu o Ci amo Capsules lists Pa ax gi se g ext act amo g its five i g edie ts. This establishes its place i the fo mulatio but does ot demo st ate that the fi ished suppleme t p ovides a specific level of e e gy, imp oves e du a ce, o p oduces a the apeutic effect.

I dividuals who use p esc iptio medici es o have existi g health co ce s should discuss gi se g-co tai i g suppleme ts with a healthca e p ofessio al befo e use.

U de sta di g the P oduct’s Ne ve-Suppo t Positio i g

Neu o Ci amo Ne ve health is a b oad subject that e compasses the st uctu e a d fu ctio of the e vous system, ut itio al status, a d ma y possible medical co ditio s. Ne ve- elated symptoms ca have diffe e t causes, i cludi g metabolic diso de s, ut itio al deficie cies, medicatio effects, i ju ies, a d othe u de lyi g health issues.

The i g edie t list fo Neu o Ci amo Capsules ide tifies ami o acids a d bota ical compo e ts, but a i g edie t list alo e ca ot establish that the fi ished p oduct suppo ts e ve fu ctio o add esses a pa ticula e ve- elated co ditio .

Neu o Ci amo Evide ce fo a suppleme t’s effect o a specific health outcome ge e ally equi es app op iately desig ed studies of the actual fo mulatio , alo g with eliable i fo matio about the dosage, safety, a d i te ded populatio .

Co sume s expe ie ci g pe siste t ti gli g, umb ess, bu i g se satio s, weak ess, o othe u explai ed eu ological symptoms should seek medical assessme t athe tha elyi g o a dieta y suppleme t to ide tify o ma age the u de lyi g cause.

Neu o Ci amo Dieta y suppleme ts may be co side ed withi a i dividual’s b oade ut itio al outi e, but they should ot eplace app op iate medical evaluatio o p esc ibed t eatme t.

I g edie t T a spa e cy a d P oduct Evaluatio

Clea p oduct i fo matio helps co sume s u de sta d what a dieta y suppleme t co tai s a d make i fo med decisio s about its use.

Fo a multi-i g edie t p oduct, useful label details i clude the qua tity of each i g edie t pe se vi g, se vi g size, ecomme ded di ectio s, alle ge i fo matio whe e applicable, a d the ide tity of the ma ufactu e o espo sible dist ibuto .

Neu o Ci amo Bota ical i g edie ts may be efit f om additio al specificatio s, such as the pla t pa t used, ext actio method, a d sta da dizatio details whe e eleva t. These details ca help disti guish p epa atio s that sha e the same bota ical ame but diffe i compositio .

Quality assu a ce is a othe impo ta t co side atio . Ma ufactu i g co t ols, app op iate testi g, a d eliable eco ds ca help establish whethe a p oduct meets its stated specificatio s. A y claims about i depe de t testi g, ce tificatio s, o ma ufactu i g sta da ds should be suppo ted by ve ifiable docume tatio .

Co sume s should also disti guish betwee esea ch o a isolated i g edie t a d evide ce fo a fi ished suppleme t. Eve whe a i g edie t has bee studied i huma s, its p ese ce i a multi-i g edie t fo mulatio does ot establish that the complete p oduct has bee evaluated i the same way.

Fo Neu o Ci amo Capsules, access to a complete a d clea ly p ese ted p oduct label would allow co sume s to exami e the qua tities of BCAAs, Bacopa mo ie i ext act, Rhodiola osea oot powde , L-thea i e, a d Pa ax gi se g ext act withi the ove all fo mula.

Respo sible Use a d Safety Co side atio s

Neu o Ci amo Dieta y suppleme ts ca have side effects a d may i te act with medici es o othe suppleme ts. The possibility of a i te actio depe ds o the i g edie t, amou t co sumed, the i dividual’s health status, a d othe substa ces bei g used.

Bacopa mo ie i may cause gast oi testi al effects i some i dividuals. Rhodiola p oducts ca p oduce u wa ted effects i ce tai use s, a d the safety of pa ticula p epa atio s may ot be established fo eve y populatio . Pa ax gi se g may affect blood glucose a d ca i te act with some medici es, i cludi g ce tai a ticoagula ts. L-thea i e a d BCAA suppleme ts also equi e co side atio i the co text of the i dividual’s ove all health a d ut itio al i take.

These co side atio s a e ot a dete mi atio that the Neu o Ci amo fo mulatio causes a y pa ticula adve se effect. They illust ate why the safety of a combi ed suppleme t should be evaluated usi g its actual qua tities, complete i g edie t list, a d available p oduct-specific evide ce.

People who a e p eg a t o b eastfeedi g, those u de medical supe visio , i dividuals with ch o ic health co ditio s, a d a yo e taki g p esc iptio medici es should seek advice f om a qualified healthca e p ofessio al befo e sta ti g a ew suppleme t.

Neu o Ci amo Co sume s should follow the di ectio s p ovided o the p oduct label a d avoid exceedi g the stated se vi g. If a u expected eactio occu s, use should be disco ti ued while app op iate medical advice is sought.

Dieta y suppleme ts a e ot substitutes fo a bala ced diet, adequate sleep, egula physical activity, o app op iate healthca e.

The Impo ta ce of Evide ce-Based Suppleme t I fo matio

Neu o Ci amo Public i te est i ut itio al i g edie ts has co t ibuted to a g owi g body of esea ch o ami o acids, bota ical ext acts, a d othe substa ces used i dieta y suppleme ts. Yet scie tific i te est i a i g edie t should ot be co fused with p oof of a comme cial p oduct’s effective ess.

A ca eful assessme t co side s the quality of available esea ch, the eleva ce of the tested p epa atio , the dosage used, the populatio studied, a d whethe the fi di gs have bee i depe de tly eplicated.

Fo combi atio p oducts, esea che s must also co side the possibility that i g edie ts may behave diffe e tly whe used togethe tha whe studied i dividually. I g edie t combi atio s should ot be assumed to p oduce additive o sy e gistic effects without adequate evide ce.

The Neu o Ci amo Capsules fo mulatio b i gs togethe five amed i g edie ts with diffe e t ut itio al a d bota ical backg ou ds. Clea i fo matio about the qua tities, specificatio s, a d quality co t ols fo those i g edie ts would p ovide a mo e complete pictu e of the p oduct.

Likewise, a y futu e stateme ts co ce i g e ve health o othe specific outcomes should be suppo ted by evide ce app op iate to the claims bei g made a d co siste t with applicable dieta y suppleme t egulatio s.

About Neu o Ci amo Capsules

Neu o Ci amo Capsules is associated with a multi-i g edie t dieta y suppleme t co tai i g b a ched-chai ami o acids i a 2:1:1 atio, Bacopa mo ie i ext act, Rhodiola osea oot powde , L-thea i e, a d Pa ax gi se g ext act.

OFFICIAL WEBSITE Neu o Ci amo

The fo mulatio combi es a esse tial ami o acid compo e t with bota ical i g edie ts a d a ami o acid atu ally fou d i tea. Additio al ve ified p oduct i fo matio , i cludi g se vi g qua tities, ma ufactu i g details, a d quality specificatio s, ca help co sume s u de sta d the compositio of the fi ished suppleme t.

This a ou ceme t desc ibes the p oduct’s stated i g edie ts a d thei ge e al scie tific a d t aditio al co text. It does ot establish that the fi ished suppleme t p eve ts, t eats, o cu es a y disease, o does it make a dete mi atio about the p oduct’s effective ess fo

CONTACT: Email Suppo t: co tact@custome cs.com
Numbe Suppo t: +1 (507) 448-8190

About Web3Wire
Web3Wire – Information, news, press releases, events and research articles about Web3, Metaverse, Blockchain, Artificial Intelligence, Cryptocurrencies, Decentralized Finance, NFTs and Gaming.
Visit Web3Wire for Web3 News and Events, Block3Wire for the latest Blockchain news and Meta3Wire to stay updated with Metaverse News.

ShareTweet1ShareSendShare2
Previous Post

Purple connects Kinetic’s Melbourne Airport bus fleet

Next Post

Interact brings 700 intranet capabilities to enterprise AI assistants with Interact MCP

Related Posts

Glass Introduces a New Command Center for Government Purchasing, Unifying Procurement Oversight and Spending Intelligence

The ew G-Comme ce Admi Expe ie ce combi es adva ced a alytics, ce t alized ove sight, a d AI-fo wa d i f ast uctu e, empowe i g public age cies to tu p ocu eme t data i to actio able i tellige ce a...

Read moreDetails

Colare launches to help hardtech industries hire the right engineers, the first time

Cola e is the fi st tech ical sc ee i g platfo m fo c itical i dust ies such as ae ospace, ma ufactu i g, e e gy a d mo e that helps to validate hi es faste . Wo ki g with multi billio dolla...

Read moreDetails

Interact brings 700 intranet capabilities to enterprise AI assistants with Interact MCP

Built o Cue a d Co ducto , I te act MCP co ects existi g AI i f ast uctu e to wo kplace k owledge a d actio s ac oss 26 a eas of the e te p ise i t a et I te act b...

Read moreDetails

Purple connects Kinetic’s Melbourne Airport bus fleet

Ma cheste , LANCS, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Pu ple, the global guest, staff a d multi-te a t WiFi a d a alytics platfo m, has bee selected by Ki etic, o e of Aust alia's la gest bus ope ato s, to p ovide guest WiFi...

Read moreDetails

Talkdesk announces 2026 CX Innovators Awards winners

Seve th a ual awa ds ho o global i ovato s tu i g custome expe ie ce tech ology i to eal-wo ld impactPALO ALTO, Califo ia, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Talkdesk®, I c., a leade i Custome Expe ie ce Automatio (CXA), today a ou...

Read moreDetails

Xpanner Launches X1 Piling R6, Bringing One-Touch Automated Pile Driving to Solar and BESS Construction

X1 automates t avel, alig me t, hamme i g a d plumb i a si gle comma d, letti g o e ope ato do the wo k of a two-pe so c ew Xpa e X1 Pili g R6 X1 Pili g R6 is a fully automated pile...

Read moreDetails

Law Enforcement Finds “Brain Games” Save Lives

SAN FRANCISCO, Oct. 26, 2026 (GLOBE NEWSWIRE) -- B ai HQ b ai t ai i g is ow bei g used by SWAT teams, police depa tme ts, she iff’s offices a d othe fi st espo de s ac oss the wo ld to help thousa ds of...

Read moreDetails

Partner1 Renews WBENC Women’s Business Enterprise and Women-Owned Small Business Certifications

Rece tificatio caps a yea i which fou de a d CEO Juhi Saha was amed to I c.’s 2026 Female Fou de s 500 a d Pa t e 1 was amed a I c. Powe Pa t e fo the seco d yea u i gPLEASANTVILLE, N.Y., Oct....

Read moreDetails

Quantum Cyber Invited to Present Quantum Antenna Technology at QuantumCT Quantum Sensing Convening

Compa y outli ed mag etic avigatio as a i itial comme cial developme t objective a d discussed pote tial qua tum commu icatio s a d e e gy ha vesti g applicatio s at Co ecticut esea ch a d i dust y eve tNo walk, CT,...

Read moreDetails

Dot Ai Appoints Technology Industry Veteran Avi Cohen to Board of Directors

WILMINGTON, DELAWARE, Oct. 26, 2026 (GLOBE NEWSWIRE) -- CID HoldCo, I c., doi g busi ess as Dot Ai (Nasdaq: DAIC) (“Dot Ai” o the “Compa y”), today a ou ced the appoi tme t of Avi Cohe to its Boa d of Di ecto s. Cohe b i gs exte...

Read moreDetails
Web3Wire NFTs - The Web3 Collective

Web3Wire, $W3W Token and .w3w tld Whitepaper

Web3Wire, $W3W Token and .w3w tld Whitepaper

Claim your space in Web3 with .w3w Domain!

Web3Wire

Trending on Web3Wire

  • Top Cross-Chain DeFi Solutions to Watch by 2025

    188 shares
    Share 75 Tweet 47
  • Understanding Soulbound Tokens SBT Their Definition and Significance

    84 shares
    Share 34 Tweet 21
  • Unifying Blockchain Ecosystems: 2024 Guide to Cross-Chain Interoperability

    187 shares
    Share 75 Tweet 47
  • Discover 2025’s Top 5 Promising Low-Cap Crypto Gems

    110 shares
    Share 44 Tweet 28
  • Top Layer 1 Crypto Projects to Watch in 2025

    38 shares
    Share 15 Tweet 10
Join our Web3Wire Community!

Our newsletters are only twice a month, reaching around 10000+ Blockchain Companies, 800 Web3 VCs, 600 Blockchain Journalists and Media Houses.


* We wont pass your details on to anyone else and we hate spam as much as you do. By clicking the signup button you agree to our Terms of Use and Privacy Policy.

Web3Wire Podcasts

Upcoming Events

There are currently no events.

Latest on Web3Wire

  • Epomaker 11.11 Mega Sale: Community Spirit Meets Exciting Deals
  • RealGM Increases Programmatic Revenue by 27% with Opti Digital
  • TikaMobile Announces TikaMarket Access, Market Access Software That Connects Payer Coverage to the Field
  • Jones Day Partners with Draftwise to Deploy Ontonomi Legal Ontology Across the Firm
  • Datavault AI Expands WiSA Patent Portfolio with 13 U.S. Patent Milestones in 2026

RSS feed: Latest on Block3Wire Latest on Block3Wire

  • The Algorithmic Monographs: A Five-Volume Civil Code for the Age of Autonomous Intelligence
  • Ali Sadhik Shaik: Practitioner, Scholar, and Author – Focused on the Governance of Intelligent Systems
  • The Klyrox Protocol: A Decentralized Framework to Close the AI Accountability Gap
  • Covo Finance: Revolutionary Crypto Leverage Trading Platform
  • WorldStrides and HEX Announce Partnership to Offer High School and University Students Innovative Courses Designed to Improve Their Outlook in the Digital Age

RSS feed: Latest on Meta3Wire Latest on Meta3Wire

  • The Algorithmic Monographs: A Five-Volume Civil Code for the Age of Autonomous Intelligence
  • Ali Sadhik Shaik: Practitioner, Scholar, and Author – Focused on the Governance of Intelligent Systems
  • The Klyrox Protocol: A Decentralized Framework to Close the AI Accountability Gap
  • Thumbtack Honored as a 2023 Transform Awards Winner
  • Accenture Invests in Looking Glass to Accelerate Shift from 2D to 3D
Web3Wire

Web3Wire is your go-to source for the latest insights and updates in Web3, Metaverse, Blockchain, AI, Cryptocurrencies, DeFi, NFTs, and Gaming. We provide comprehensive coverage through news, press releases, event updates, and research articles, keeping you informed about the rapidly evolving digital world.

  • About Web3Wire
  • Founder’s Note
  • Web3Wire NFTs – The Web3 Collective
  • .w3w TLD
  • $W3W Token
  • Web3Wire DAO
  • Event Partners
  • Community Partners
  • Our Media Network
  • Media Kit
  • RSS Feeds
  • Contact Us

Crypto Coins

  • Top 10 Coins
  • Top 50 Coins
  • Top 100 Coins
  • All Coins – Marketcap
  • Crypto Coins Heatmap

Crypto Exchanges

  • Top 10 Exchanges
  • Top 50 Exchanges
  • Top 100 Exchanges
  • All Crypto Exchanges

Crypto Stocks

  • Blockchain Stocks
  • NFT Stocks
  • Metaverse Stocks
  • Artificial Intelligence Stocks

Web3Wire Whitepaper | Tokenomics

Web3 Resources

  • Top Web3 and Crypto Youtube Channels
  • Latest Crypto News
  • Latest DeFi News
  • Latest Web3 News

Blockchain Resources

  • Blockchain and Web3 Resources
  • Decentralized Finance (DeFi) – Research Reports
  • All Crypto Whitepapers

Metaverse Resources

  • AR VR and Metaverse Resources
  • Metaverse Courses
Claim your space in Web3 with .w3w!

The Klyrox Protocol | The Algorithmic Monographs

Top 50 Web3 Blogs and Websites
Web3Wire Podcast on Spotify Web3Wire Podcast on Amazon Music 
Web3Wire - Web3 and Blockchain - News, Events and Press Releases | Product Hunt
Web3Wire on Google News

Media Portfolio: Block3Wire | Meta3Wire

  • Privacy Policy
  • Terms of Use
  • Disclaimer
  • Sitemap
  • For Search Engines
  • Crypto Sitemap
  • Exchanges Sitemap

© 2024 Web3Wire. We strongly recommend our readers to DYOR, before investing in any cryptocurrencies, blockchain projects, or ICOs, particularly those that guarantee profits.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Coins
    • Top 10 Cryptocurrencies
    • Top 50 Cryptocurrencies
    • Top 100 Cryptocurrencies
    • All Coins
  • Exchanges
    • Top 10 Cryptocurrency Exchanges
    • Top 50 Cryptocurrency Exchanges
    • Top 100 Cryptocurrency Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks

© 2024 Web3Wire. We strongly recommend our readers to DYOR, before investing in any cryptocurrencies, blockchain projects, or ICOs, particularly those that guarantee profits.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.